Michael Boyne

Michael Boyne, PhD. is currently the senior vice president of product development and operations at COUR Pharmaceuticals. Before joining COUR, he was a Senior Consultant at BioTechLogic where he advised pharmaceutical manufacturers on drug development and CMC strategy, including drafting, reviewing, and authoring Pharmaceutical Quality/CMC sections (Module 3) of the CTD for regulatory submissions. Prior to consulting, he was a Research Chemist in the Division of Pharmaceutical Analysis at the US Food and Drug Administration where he established a laboratory developing and applying modern analytical technologies for the evaluation and regulation of complex drug products. Michael has authored over 50 peer-reviewed publications and is an internationally recognized speaker on the application of modern analytical technologies and CMC development.

Michael was a postdoctoral scholar at Washington University Medical School in Saint Louis where he was an American Cancer Society/Canary Foundation Fellow in Early Detection. Michael has a BA in Chemistry from Northwestern University, Evanston, IL and a PhD in Chemistry from the University of Illinois Urbana-Champaign.